check_circleStudy Completed
Fever, Migraine, Pain
Bayer Identifier:
12011
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
EU CT Number:
Not Available
BAY81-8781 Thrombocyte inhibition, pharmacokinetics
Trial purpose
Primary Objective:
To investigate the function of platelets after different single doses of
acetylsalicylic acid (ASA) given as intravenous (IV) BAY 81-8781 and
Aspirin® tablets in comparison to inactive intravenous (IV) treatment.
Secondary Objective:
To investigate safety, tolerability, and pharmacokinetics of these
treatments.
To investigate the function of platelets after different single doses of
acetylsalicylic acid (ASA) given as intravenous (IV) BAY 81-8781 and
Aspirin® tablets in comparison to inactive intravenous (IV) treatment.
Secondary Objective:
To investigate safety, tolerability, and pharmacokinetics of these
treatments.
Key Participants Requirements
Sex
N/AAge
40 - 58 YearsTrial summary
Enrollment Goal
22Trial Dates
July 2006 - December 2006Phase
Phase 1Could I Receive a placebo
N/AProducts
Aspirin (Acetylsalicylic Acid, BAY81-8781)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Wuppertal, 42096, Germany |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
RandomizedBlinding
N/AAssignment
Crossover AssignmentTrial Arms
N/A